SCHEMBL13768935

SCHEMBL13768935

CC(C)(C)OC(=O)/C(F)=C/CCCCCNC(=O)NC12CC3CCCC(C3)(C1)C2

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4015544 0.83 EPHX2 (0.67) EPHX2
SCHEMBL4015539 0.83 EPHX2 (0.67) EPHX2
SCHEMBL13768934 0.83 EPHX2 (0.44) EPHX2
SCHEMBL13768936 0.83 EPHX2 (0.43) EPHX2
SCHEMBL13768656 0.75 EPHX2 (0.45) EPHX2
SCHEMBL13768655 0.75 EPHX2 (0.45) EPHX2
SCHEMBL4010209 0.73 EPHX2 (0.64) EPHX2
SCHEMBL4010213 0.73 EPHX2 (0.64) EPHX2
SCHEMBL13768657 0.73 EPHX2 (0.45) EPHX2
SCHEMBL13651416 0.70 EPHX2 (0.66) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009086429-A1 SOLUBLE EPOXIDE HYDROLASE INHIBITORS ARETE THERAPEUTICS, INC. (US) 2009-07-09 WO disclosed
WO-2009086426-A2 SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION ARETE THERAPEUTICS, INC. (US) 2009-07-09 WO disclosed